Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	STAB2 LDLR STAB1 SORL1	2.21e-06	16	121	4	GO:0005041
GeneOntologyMolecularFunction	low-density lipoprotein particle binding	STAB2 LDLR STAB1 SORL1	3.68e-06	18	121	4	GO:0030169
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	STAB2 LDLR STAB1 SORL1	7.09e-06	21	121	4	GO:0030228
GeneOntologyMolecularFunction	lipoprotein particle binding	STAB2 LDLR STAB1 SORL1	5.81e-05	35	121	4	GO:0071813
GeneOntologyMolecularFunction	protein-lipid complex binding	STAB2 LDLR STAB1 SORL1	5.81e-05	35	121	4	GO:0071814
GeneOntologyBiologicalProcess	neuroinflammatory response	LDLR ZEB2 PTPRC CLU VPS13A PLCG2	2.89e-05	101	121	6	GO:0150076
GeneOntologyBiologicalProcess	mammillary body development	ZEB2 FOXB1	3.41e-05	2	121	2	GO:0021767
GeneOntologyBiologicalProcess	mammillary axonal complex development	ZEB2 FOXB1	3.41e-05	2	121	2	GO:0061373
GeneOntologyCellularComponent	cell projection membrane	TRPM6 TCTN3 PDE6A ANPEP EPB41L5 AQP1 SHANK2 CLTB ANTXR1 PLCG2 ATP1B2	3.90e-05	431	120	11	GO:0031253
GeneOntologyCellularComponent	procentriole	CEP192 CEP152	9.77e-05	3	120	2	GO:0120098
GeneOntologyCellularComponent	HULC complex	UBE2A UBE2B	1.95e-04	4	120	2	GO:0033503
GeneOntologyCellularComponent	distal axon	AQP1 SLC1A1 ZNF804A TENM2 NEO1 SHANK2 FEZ1 CLU CDH8 AP3D1	2.08e-04	435	120	10	GO:0150034
GeneOntologyCellularComponent	procentriole replication complex	CEP192 CEP152	4.83e-04	6	120	2	GO:0120099
Domain	Alpha_kinase	TRPM6 ALPK1 EEF2K	4.97e-06	6	119	3	PF02816
Domain	MHCK_EF2_kinase	TRPM6 ALPK1 EEF2K	4.97e-06	6	119	3	IPR004166
Domain	ALPHA_KINASE	TRPM6 ALPK1 EEF2K	4.97e-06	6	119	3	PS51158
Domain	Alpha_kinase	TRPM6 ALPK1 EEF2K	4.97e-06	6	119	3	SM00811
Domain	Hud_Sxl_RNA	RBMS2 ELAVL2 ELAVL1	2.93e-05	10	119	3	IPR002343
Domain	FAS1	STAB2 STAB1	2.40e-04	4	119	2	SM00554
Domain	FAS1_domain	STAB2 STAB1	2.40e-04	4	119	2	IPR000782
Domain	ELAD_HUD_SF	ELAVL2 ELAVL1	2.40e-04	4	119	2	IPR006548
Domain	-	STAB2 STAB1	2.40e-04	4	119	2	2.30.180.10
Domain	FAS1	STAB2 STAB1	2.40e-04	4	119	2	PS50213
Domain	Fasciclin	STAB2 STAB1	2.40e-04	4	119	2	PF02469
Domain	TF_Brachyury	TBX2 TBX6	5.94e-04	6	119	2	IPR002070
Domain	EGF-like_dom	STAB2 IMPG1 TENM2 LDLR STAB1 NRG3 SORL1	1.09e-03	249	119	7	IPR000742
Domain	Prot_inh_cystat_CS	CST6 CSTB	1.41e-03	9	119	2	IPR018073
Domain	EGF-like_CS	STAB2 TENM2 LDLR ITGB7 STAB1 NRG3 SORL1	1.42e-03	261	119	7	IPR013032
Domain	PTPc	PTPN11 PTPN13 PTPRC	1.54e-03	36	119	3	SM00194
Domain	EGF_2	STAB2 TENM2 LDLR ITGB7 STAB1 NRG3 SORL1	1.55e-03	265	119	7	PS01186
Domain	E3_UB_ligase_RBR	ARIH2 ARIH1	1.75e-03	10	119	2	IPR031127
Domain	TYR_PHOSPHATASE_PTP	PTPN11 PTPN13 PTPRC	1.95e-03	39	119	3	PS50055
Domain	-	TENM2 LDLR SORL1	1.95e-03	39	119	3	2.120.10.30
Domain	LDLR_class-A_CS	LDLR RXFP1 SORL1	2.10e-03	40	119	3	IPR023415
Domain	GFP-like	STAB2 STAB1	2.13e-03	11	119	2	IPR023413
Domain	-	STAB2 STAB1	2.13e-03	11	119	2	2.40.155.10
Domain	PTPase_domain	PTPN11 PTPN13 PTPRC	2.25e-03	41	119	3	IPR000242
Domain	Y_phosphatase	PTPN11 PTPN13 PTPRC	2.25e-03	41	119	3	PF00102
Domain	EGF_dom	STAB2 STAB1	2.55e-03	12	119	2	IPR024731
Domain	CYSTATIN	CST6 CSTB	2.55e-03	12	119	2	PS00287
Domain	EGF_3	STAB2 STAB1	2.55e-03	12	119	2	PF12947
Domain	Ldl_recept_a	LDLR RXFP1 SORL1	2.94e-03	45	119	3	PF00057
Domain	Link_dom	STAB2 STAB1	3.00e-03	13	119	2	IPR000538
Domain	Xlink	STAB2 STAB1	3.00e-03	13	119	2	PF00193
Domain	LINK_2	STAB2 STAB1	3.00e-03	13	119	2	PS50963
Domain	LINK	STAB2 STAB1	3.00e-03	13	119	2	SM00445
Domain	LINK_1	STAB2 STAB1	3.00e-03	13	119	2	PS01241
Domain	6-blade_b-propeller_TolB-like	TENM2 LDLR SORL1	3.14e-03	46	119	3	IPR011042
Domain	-	LDLR RXFP1 SORL1	3.14e-03	46	119	3	4.10.400.10
Domain	IBR	ARIH2 ARIH1	3.48e-03	14	119	2	PF01485
Domain	SEA	IMPG1 MUC16	3.48e-03	14	119	2	SM00200
Domain	IBR	ARIH2 ARIH1	3.48e-03	14	119	2	SM00647
Domain	Ldl_recept_b	LDLR SORL1	3.48e-03	14	119	2	PF00058
Domain	LDLRB	LDLR SORL1	3.48e-03	14	119	2	PS51120
Domain	LDLRA_1	LDLR RXFP1 SORL1	3.54e-03	48	119	3	PS01209
Domain	LDrepeatLR_classA_rpt	LDLR RXFP1 SORL1	3.75e-03	49	119	3	IPR002172
Domain	LDLa	LDLR RXFP1 SORL1	3.75e-03	49	119	3	SM00192
Domain	LDLRA_2	LDLR RXFP1 SORL1	3.75e-03	49	119	3	PS50068
Domain	Znf_RING_CS	ARIH2 RNF10 TRIM8 HLTF SCAF11	3.91e-03	163	119	5	IPR017907
Domain	EGF	STAB2 TENM2 LDLR STAB1 NRG3 SORL1	3.97e-03	235	119	6	SM00181
Domain	EGF_3	STAB2 TENM2 LDLR STAB1 NRG3 SORL1	3.97e-03	235	119	6	PS50026
Domain	-	IMPG1 MUC16	4.00e-03	15	119	2	3.30.70.960
Domain	LY	LDLR SORL1	4.00e-03	15	119	2	SM00135
Domain	IBR_dom	ARIH2 ARIH1	4.00e-03	15	119	2	IPR002867
Domain	LDLR_classB_rpt	LDLR SORL1	4.00e-03	15	119	2	IPR000033
Domain	p53-like_TF_DNA-bd	NFAT5 TBX2 TBX6	4.69e-03	53	119	3	IPR008967
Domain	TF_T-box	TBX2 TBX6	5.14e-03	17	119	2	IPR001699
Domain	TBOX	TBX2 TBX6	5.14e-03	17	119	2	SM00425
Domain	TF_T-box_CS	TBX2 TBX6	5.14e-03	17	119	2	IPR018186
Domain	-	TBX2 TBX6	5.14e-03	17	119	2	2.60.40.820
Domain	TBOX_3	TBX2 TBX6	5.14e-03	17	119	2	PS50252
Domain	T-box	TBX2 TBX6	5.14e-03	17	119	2	PF00907
Domain	CY	CST6 CSTB	5.14e-03	17	119	2	SM00043
Domain	TBOX_1	TBX2 TBX6	5.14e-03	17	119	2	PS01283
Domain	TBOX_2	TBX2 TBX6	5.14e-03	17	119	2	PS01264
Domain	Cystatin_dom	CST6 CSTB	5.76e-03	18	119	2	IPR000010
Domain	Cystatin	CST6 CSTB	5.76e-03	18	119	2	PF00031
Domain	EGF_1	STAB2 TENM2 LDLR ITGB7 STAB1 NRG3	5.88e-03	255	119	6	PS00022
Domain	PTPc_motif	PTPN11 PTPN13 PTPRC	6.33e-03	59	119	3	SM00404
Domain	Tyr_Pase_cat	PTPN11 PTPN13 PTPRC	6.33e-03	59	119	3	IPR003595
Pubmed	Systems biology of the 2-cell mouse embryo.	MBTD1 ELAVL2 ELAVL1 BTG4	1.01e-07	13	122	4	15237213
Pubmed	Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression.	STAB2 LDLR STAB1	1.68e-07	4	122	3	36325910
Pubmed	Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions.	APOB LDLR PTPRC	1.68e-07	4	122	3	22144566
Pubmed	Evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of European descent.	SYCP2 UBE2B BRCA2 BRDT SPATA22	2.92e-07	40	122	5	20378615
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MECOM CEP192 LDLR ZEB2 BUB1B MKI67 CEP152 MED23	3.03e-07	184	122	8	32908313
Pubmed	Alpha-kinases: a new class of protein kinases with a novel catalytic domain.	TRPM6 ALPK1 EEF2K	8.36e-07	6	122	3	10021370
Pubmed	Mature mRNA processing that deletes 3' end sequences directs translational activation and embryonic development.	GEMIN5 ELAVL2 ELAVL1	1.46e-06	7	122	3	38000026
Pubmed	Intra-aortic clusters undergo endothelial to hematopoietic phenotypic transition during early embryogenesis.	MECOM PTPRC MKI67	2.33e-06	8	122	3	22558218
Pubmed	Tagging genes with cassette-exchange sites.	MBTD1 GEMIN5 RFX7 PTPN11 MKI67 NAV2 SECISBP2 MED23 ZNF292	3.01e-06	335	122	9	15741177
Pubmed	Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.	LDLR CLU SORL1	3.48e-06	9	122	3	20005821
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	PLXNA3 PTBP3 TCTN3 MBTD1 CDV3 GJC1 MECOM PTPN11 FEZ1 RALGPS1 ARIH2 CLTB VPS13A ELAVL2 CEP152 CCDC33	5.68e-06	1215	122	16	15146197
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 MBTD1 MBNL1 AKNAD1 GEMIN5 APOB CEP192 LDLR PPARGC1A PTPN13 PTPRC RASSF1 PEAK1 NFAT5 BTG4	6.34e-06	1084	122	15	11544199
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PTBP3 CDV3 RBMS2 MBNL1 EPB41L5 GEMIN5 DARS1 PTPN13 MKI67 SECISBP2 MAP2K3 ZNF292	9.74e-06	724	122	12	36232890
Pubmed	Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	11947895
Pubmed	Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation.	APOB LDLR	1.22e-05	2	122	2	14967814
Pubmed	[A genetic and clinical study in a family with familial hypercholesterolemia].	APOB LDLR	1.22e-05	2	122	2	21418831
Pubmed	Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance TRAFFn, T1ρ and T2 relaxation times.	APOB LDLR	1.22e-05	2	122	2	36709358
Pubmed	Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine.	APOB LDLR	1.22e-05	2	122	2	35145523
Pubmed	Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China.	APOB LDLR	1.22e-05	2	122	2	22353362
Pubmed	The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice.	UBE2A UBE2B	1.22e-05	2	122	2	15169909
Pubmed	FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.	STAB2 STAB1	1.22e-05	2	122	2	12473645
Pubmed	Targeting HuR-Vav3 mRNA interaction prevents Pseudomonas aeruginosa adhesion to the cystic fibrosis airway epithelium.	ELAVL1 VAV3	1.22e-05	2	122	2	36602863
Pubmed	Loss of HR6B ubiquitin-conjugating activity results in damaged synaptonemal complex structure and increased crossing-over frequency during the male meiotic prophase.	UBE2A UBE2B	1.22e-05	2	122	2	12556476
Pubmed	Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity.	APOB LDLR	1.22e-05	2	122	2	36950286
Pubmed	LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population.	APOB LDLR	1.22e-05	2	122	2	17964958
Pubmed	Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6.	UBE2A UBE2B	1.22e-05	2	122	2	1717990
Pubmed	Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.	APOB LDLR	1.22e-05	2	122	2	24349031
Pubmed	Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks.	BRCA2 RASSF1	1.22e-05	2	122	2	25927241
Pubmed	Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population.	APOB LDLR	1.22e-05	2	122	2	20019594
Pubmed	Echium oil reduces atherosclerosis in apoB100-only LDLrKO mice.	APOB LDLR	1.22e-05	2	122	2	22100249
Pubmed	Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice.	APOB LDLR	1.22e-05	2	122	2	21357823
Pubmed	Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow.	APOB LDLR	1.22e-05	2	122	2	22268108
Pubmed	Capillary Dynamics Regulate Post-Ischemic Muscle Damage and Regeneration in Experimental Hindlimb Ischemia.	APOB LDLR	1.22e-05	2	122	2	37626870
Pubmed	Localization of two human homologs, HHR6A and HHR6B, of the yeast DNA repair gene RAD6 to chromosomes Xq24-q25 and 5q23-q31.	UBE2A UBE2B	1.22e-05	2	122	2	1559696
Pubmed	Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.	APOB LDLR	1.22e-05	2	122	2	15637307
Pubmed	Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.	APOB LDLR	1.22e-05	2	122	2	22837469
Pubmed	Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.	APOB LDLR	1.22e-05	2	122	2	26178198
Pubmed	Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver.	STAB2 STAB1	1.22e-05	2	122	2	21427291
Pubmed	Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.	APOB LDLR	1.22e-05	2	122	2	19834103
Pubmed	Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.	APOB LDLR	1.22e-05	2	122	2	25830298
Pubmed	[Low density lipoprotein receptor gene mutations in patients with clinical diagnosis of familial hypercholesterolemia.].	APOB LDLR	1.22e-05	2	122	2	15477777
Pubmed	The NMR structure of the class I human ubiquitin-conjugating enzyme 2b.	UBE2A UBE2B	1.22e-05	2	122	2	11885984
Pubmed	Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model.	ODC1 ELAVL1	1.22e-05	2	122	2	20685649
Pubmed	Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia.	APOB LDLR	1.22e-05	2	122	2	11737238
Pubmed	Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.	APOB LDLR	1.22e-05	2	122	2	21372297
Pubmed	Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus.	APOB LDLR	1.22e-05	2	122	2	25231636
Pubmed	Molecular genetic testing for familial hypercholesterolemia in the Netherlands: a stepwise screening strategy enhances the mutation detection rate.	APOB LDLR	1.22e-05	2	122	2	16792510
Pubmed	Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding.	STAB2 STAB1	1.22e-05	2	122	2	15572036
Pubmed	Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice.	STAB2 STAB1	1.22e-05	2	122	2	38946049
Pubmed	Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding.	APOB LDLR	1.22e-05	2	122	2	12031600
Pubmed	ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation.	ELAVL2 ELAVL1	1.22e-05	2	122	2	9763509
Pubmed	Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.	APOB LDLR	1.22e-05	2	122	2	16129816
Pubmed	Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.	BRCA2 BUB1B	1.22e-05	2	122	2	10749118
Pubmed	Recombinant RXFP1-LDL-A module does not form dimers.	LDLR RXFP1	1.22e-05	2	122	2	24640556
Pubmed	siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.	APOB LDLR	1.22e-05	2	122	2	21398511
Pubmed	Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.	APOB LDLR	1.22e-05	2	122	2	17347910
Pubmed	Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.	APOB LDLR	1.22e-05	2	122	2	23505495
Pubmed	Genetic screening for familial hypercholesterolemia identifies patients not meeting cholesterol treatment guidelines.	APOB LDLR	1.22e-05	2	122	2	33394692
Pubmed	Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid.	APOB LDLR	1.22e-05	2	122	2	16957181
Pubmed	Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.	APOB LDLR	1.22e-05	2	122	2	29353225
Pubmed	FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities.	STAB2 STAB1	1.22e-05	2	122	2	12077138
Pubmed	Differential Promoter Methylation of Macrophage Genes Is Associated With Impaired Vascular Growth in Ischemic Muscles of Hyperlipidemic and Type 2 Diabetic Mice: Genome-Wide Promoter Methylation Study.	APOB LDLR	1.22e-05	2	122	2	26085133
Pubmed	Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	15890894
Pubmed	Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform.	APOB LDLR	1.22e-05	2	122	2	19318025
Pubmed	Combined BubR1 protein down-regulation and RASSF1A hypermethylation in Wilms tumors with diverse cytogenetic changes.	RASSF1 BUB1B	1.22e-05	2	122	2	18286482
Pubmed	Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	21722902
Pubmed	Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.	UBE2A UBE2B	1.22e-05	2	122	2	31683936
Pubmed	CLU (clusterin) and PPARGC1A/PGC1α coordinately control mitophagy and mitochondrial biogenesis for oral cancer cell survival.	PPARGC1A CLU	1.22e-05	2	122	2	38447939
Pubmed	Familial hypercholesterolemia and coronary heart disease: a HuGE association review.	APOB LDLR	1.22e-05	2	122	2	15321838
Pubmed	Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.	APOB LDLR	1.22e-05	2	122	2	15321837
Pubmed	Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.	APOB LDLR	1.22e-05	2	122	2	15321839
Pubmed	A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus.	LDLR ELAVL1	1.22e-05	2	122	2	33262333
Pubmed	Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.	APOB LDLR	1.22e-05	2	122	2	26748104
Pubmed	Scavenging Endothelium of Pancreatic Islets: Differential Expression of Stabilin-1 and Stabilin-2 in Mice and Humans.	STAB2 STAB1	1.22e-05	2	122	2	27977633
Pubmed	Radiosynthesis and preclinical evaluation of [68Ga]Ga-NOTA-folate for PET imaging of folate receptor β-positive macrophages.	APOB LDLR	1.22e-05	2	122	2	32788595
Pubmed	Linkage genetics of mouse ornithine decarboxylase (Odc).	APOB ODC1	1.22e-05	2	122	2	2575591
Pubmed	Monounsaturated fatty acyl-coenzyme A is predictive of atherosclerosis in human apoB-100 transgenic, LDLr-/- mice.	APOB LDLR	1.22e-05	2	122	2	17277381
Pubmed	Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.	APOB LDLR	1.22e-05	2	122	2	15630635
Pubmed	Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor.	APOB LDLR	1.22e-05	2	122	2	30508567
Pubmed	RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.	UBE2A UBE2B	1.22e-05	2	122	2	28806395
Pubmed	Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.	APOB LDLR	1.22e-05	2	122	2	18794388
Pubmed	Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	17872464
Pubmed	Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100.	APOB LDLR	1.22e-05	2	122	2	34914849
Pubmed	Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	20506408
Pubmed	Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia.	APOB LDLR	1.22e-05	2	122	2	15701167
Pubmed	Identifying Stabilin-1 and Stabilin-2 Double Knockouts in Reproduction and Placentation: A Descriptive Study.	STAB2 STAB1	1.22e-05	2	122	2	33008099
Pubmed	ApoB100,LDLR-/- mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina.	APOB LDLR	1.22e-05	2	122	2	18385042
Pubmed	Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.	APOB LDLR	1.22e-05	2	122	2	19007590
Pubmed	The expression of aquaporin-1 in the medulla of the kidney is dependent on the transcription factor associated with hypertonicity, TonEBP.	AQP1 NFAT5	1.22e-05	2	122	2	20639513
Pubmed	Impact of sex and sex hormones on pathophysiology and progression of aortic stenosis in a murine model.	APOB LDLR	1.22e-05	2	122	2	36029186
Pubmed	Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells.	STAB2 STAB1	1.22e-05	2	122	2	33130055
Pubmed	The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population.	APOB LDLR	1.22e-05	2	122	2	15823288
Pubmed	Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha).	LDLR PPARGC1A	1.22e-05	2	122	2	19322023
Pubmed	Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.	APOB LDLR	1.22e-05	2	122	2	16389549
Pubmed	Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia.	APOB LDLR	1.22e-05	2	122	2	12492446
Pubmed	Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes.	APOB LDLR	1.22e-05	2	122	2	17566095
Pubmed	Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	16596945
Pubmed	Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.	APOB LDLR	1.22e-05	2	122	2	18940289
Pubmed	T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation.	OLFM4 ITGB7	1.22e-05	2	122	2	31278057
Pubmed	Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor.	APOB LDLR	1.22e-05	2	122	2	15797858
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PTBP3 SMG1 CDV3 EP400 DCP2 MBNL1 EVI2B DARS1 ODC1 RFX7 ITGB7 ZEB2 PTPN11 SAMD9L PTPRC SECISBP2 SCAF11 VAV3 GPR171 ARIH1 NFAT5 ZNF292 SORL1	3.53e-07	1492	122	23	M40023
Coexpression	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	PTBP3 CDV3 AOX1 PTPN11 FEZ1 ELAVL2 SORL1	2.13e-06	126	122	7	M2309
Coexpression	PUJANA_ATM_PCC_NETWORK	CDV3 EP400 RBMS2 DCP2 MBNL1 DARS1 ODC1 ZNF804A ITGB7 PTPRC RASSF1 ARIH2 CLTB MKI67 ELAVL1 SCAF11 GPR171 PLCG2 CDH8 TBX6	6.71e-06	1394	122	20	M9585
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MON2 PLXNA3 CDV3 CEP192 SLC1A1 ZEB2 NEO1 SAMD9L UBE2B LRRC42 RALGPS1 NAV2 ELAVL1 TMEM108 ATP1B2 TBX2 SORL1	1.42e-05	1102	122	17	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MON2 PLXNA3 CDV3 CEP192 SLC1A1 ZEB2 NEO1 SAMD9L UBE2B LRRC42 RALGPS1 NAV2 ELAVL1 TMEM108 ATP1B2 TBX2 SORL1	1.83e-05	1124	122	17	MM1070
Coexpression	GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	EVI2B RFX7 BUB1B MKI67 TMEM108 ZNF292 SORL1	4.33e-05	200	122	7	M8088
Coexpression	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	MBTD1 USP22 DCP2 TRIM8 HLTF ELAVL1 SORL1	4.33e-05	200	122	7	M3277
Coexpression	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	CABYR SYCP2 BRDT SPATA22	4.79e-05	43	122	4	M16646
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	TRPM6 MECOM CA10 ZNF518A PPARGC1A NAV2 VAV3	5.55e-05	208	122	7	M39233
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	EPB41L5 MECOM AQP1 CA10 TENM2 PPARGC1A FOXB1 PTPN13 FEZ1 CLU ANTXR1 ELAVL2 TMEM108 PEAK1 NRG3 ARHGAP20 CDH8 CCDC33 TBX2	2.32e-06	976	120	19	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_200	EPB41L5 PPARGC1A SAMD9L HLTF VAV3 NFAT5 SORL1	3.00e-05	156	120	7	gudmap_developingKidney_e15.5_cortic collect duct_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	ANPEP MUC16 ALPK1 ZEB2 NEO1 PTPN13 CLU NAV2 ANTXR1 PEAK1 ARHGAP20 ATP1B2 NFAT5 AKAP7	7.60e-05	740	120	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100	MUC16 PPARGC1A CLU ARHGAP20 ATP1B2	8.05e-05	78	120	5	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_100
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500	MECOM AQP1 TENM2 PPARGC1A FEZ1 ANTXR1 PEAK1 NRG3 ARHGAP20 CDH8 TBX2	1.05e-04	489	120	11	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	EPB41L5 MECOM AQP1 TENM2 PPARGC1A FEZ1 RALGPS1 NAV2 ANTXR1 ELAVL2 PEAK1 NRG3 ARHGAP20 CDH8 CCDC33 TBX2	1.35e-04	984	120	16	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	ANPEP DCP2 MUC16 ALPK1 ZEB2 NEO1 PTPN13 NAV2 ANTXR1 PEAK1 ARHGAP20 ATP1B2 NFAT5 AKAP7	1.38e-04	783	120	14	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2	EPB41L5 MECOM PPARGC1A FEZ1 RALGPS1 ELAVL2 NRG3 CDH8	1.90e-04	279	120	8	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_200	PPARGC1A SAMD9L HLTF	2.17e-04	21	120	3	gudmap_developingKidney_e15.5_cortic collect duct_200_k4
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100	PPARGC1A CLU ATP1B2	2.17e-04	21	120	3	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k3_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	MUC16 PPARGC1A CLU TMEM108 ARHGAP20 ATP1B2	2.36e-04	153	120	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200	EPB41L5 PPARGC1A VAV3 NFAT5	2.47e-04	54	120	4	gudmap_developingKidney_e15.5_cortic collect duct_200_k3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4	MECOM PPARGC1A FEZ1 CLTB NRG3 ATP1B2 CDH8	2.79e-04	223	120	7	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500	ZNF518A SYCP2 BRCA2 BRDT	2.84e-04	56	120	4	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2	MECOM PPARGC1A FEZ1 NRG3 CDH8	2.98e-04	103	120	5	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500	SMG1 EPB41L5 PPARGC1A VPS13A VAV3 NFAT5	3.31e-04	163	120	6	gudmap_developingKidney_e15.5_cortic collect duct_500_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	CDV3 EPB41L5 TENM2 LDLR VPS13A ELAVL2 CDH8	3.46e-04	231	120	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4	MECOM PPARGC1A FEZ1 CLTB NRG3 ATP1B2 CDH8	3.55e-04	232	120	7	Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000	PTBP3 STAB2 EVI2B AQP1 ZEB2 STAB1 EHBP1L1 SAMD9L PTPRC HLTF VAV3 PEAK1 NFAT5	3.74e-04	761	120	13	gudmap_developingKidney_e15.5_Endothelial cells_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500	SMG1 EPB41L5 PPARGC1A SAMD9L VPS13A HLTF VAV3 NFAT5 SORL1	3.78e-04	390	120	9	gudmap_developingKidney_e15.5_cortic collect duct_500
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 CDV3 MBNL1 ZEB2 SAMD9L PTPRC SCAF11 PLCG2 ZNF292	4.47e-09	200	122	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	EPB41L5 MECOM SLC1A1 PPARGC1A SHANK2 NAV2 NRG3 AKAP7	2.82e-08	174	122	8	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 MECOM SLC1A1 PPARGC1A SHANK2 NAV2 PEAK1 NRG3	4.35e-08	184	122	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 MECOM SLC1A1 PPARGC1A SHANK2 NAV2 PEAK1 NRG3	4.35e-08	184	122	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MON2 SMG1 MBNL1 LDLR ZEB2 PTPRC ARIH1 NFAT5	5.13e-08	188	122	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	IPF-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	RBMS2 ZEB2 NEO1 ANTXR1 TMEM108 RXFP1 NRG3 ADAMTSL2	7.08e-08	196	122	8	8f0f72ead06abe02b575e443552eacc2151077ef
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 MBNL1 AQP1 PTPRC VPS13A PLCG2 MED23 ZNF292	7.36e-08	197	122	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 PTBP3 OLFM4 PPARGC1A PTPN13 CLU NFAT5 TBX2	7.96e-08	199	122	8	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA AOX1 MECOM LDLR BRCA2 CLU BUB1B	3.85e-07	166	122	7	575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	EPB41L5 MECOM LDLR SHANK2 NAV2 NRG3 AKAP7	4.52e-07	170	122	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 OLFM4 MECOM PPARGC1A PTPN13 CLU CST6	7.69e-07	184	122	7	9690d4290e70f9bda889754ffb30b0af1f7cb94b
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	EPB41L5 MECOM LDLR PTPN13 SHANK2 NAV2 TMEM108	8.27e-07	186	122	7	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 OLFM4 MECOM PPARGC1A PTPN13 CLU TBX2	8.27e-07	186	122	7	b3358e0fa6d845c81e94d56c8575f016621d28ff
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM CA10 PPARGC1A RANBP3L TMEM108 VAV3	8.88e-07	188	122	7	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	EPB41L5 MECOM SLC1A1 LDLR PTPN13 SHANK2 NAV2	8.88e-07	188	122	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	kidney_cells-Hypertensive_with+without-CKD\|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 MECOM PTPN13 RANBP3L CLU NFAT5 SORL1	8.88e-07	188	122	7	90188b60ff893754f7938fe8edab79758827168e
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	EPB41L5 MECOM SLC1A1 LDLR PTPN13 SHANK2 AGBL1	8.88e-07	188	122	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM CA10 PPARGC1A RANBP3L RALGPS1 NAV2	9.20e-07	189	122	7	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTBP3 CDV3 APOB ZNF518A SAMD9L SCAF11 ARHGAP20	9.88e-07	191	122	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	Adult-Immune-monocyte-D175\|Adult / Lineage, Cell type, age group and donor	ZNF804A ZEB2 STAB1 EHBP1L1 PTPRC VAV3 PLCG2	9.88e-07	191	122	7	cbebb4d9550fdcd606cb3685ac9546c6b73fd422
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTBP3 CDV3 APOB ZNF518A SAMD9L SCAF11 ARHGAP20	9.88e-07	191	122	7	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CA10 PPARGC1A SHANK2 RANBP3L RALGPS1 NAV2	9.88e-07	191	122	7	963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	EPB41L5 MECOM SLC1A1 PTPN13 SHANK2 NAV2 AKAP7	9.88e-07	191	122	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTBP3 CDV3 APOB ZNF518A SAMD9L SCAF11 ARHGAP20	9.88e-07	191	122	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	EPB41L5 MECOM LDLR PTPN13 SHANK2 NAV2 AGBL1	1.02e-06	192	122	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MON2 SMG1 MBNL1 LDLR PTPRC ARIH1 SORL1	1.02e-06	192	122	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	ZEB2 STAB1 PTPRC BRCA2 BUB1B MKI67 VAV3	1.02e-06	192	122	7	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	EPB41L5 MECOM LDLR PTPN13 SHANK2 NAV2 AGBL1	1.02e-06	192	122	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	ZEB2 STAB1 PTPRC BRCA2 BUB1B MKI67 VAV3	1.06e-06	193	122	7	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	MON2 MBNL1 UBE2B SCAF11 PLCG2 NFAT5 ZNF292	1.06e-06	193	122	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 OLFM4 PPARGC1A PTPN13 VAV3 ATP1B2 TBX2	1.13e-06	195	122	7	3f517c6fc372bdcaf45b3af373414f13cbebd4ba
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TENM2 ZEB2 NEO1 ANTXR1 TMEM108 ARHGAP20 TBX2	1.13e-06	195	122	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L5 MECOM PPARGC1A PTPN13 SHANK2 RALGPS1 VAV3	1.13e-06	195	122	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 MECOM SLC1A1 LDLR PTPN13 SHANK2 NAV2	1.13e-06	195	122	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 NEK10 MECOM PTPN13 SHANK2 VAV3 SORL1	1.17e-06	196	122	7	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L5 MECOM PPARGC1A PTPN13 SHANK2 RALGPS1 VAV3	1.17e-06	196	122	7	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	EPB41L5 MECOM PTPN13 SHANK2 NAV2 PEAK1 AGBL1	1.26e-06	198	122	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 OLFM4 PPARGC1A ELAVL2 PLCG2 CDH8	2.16e-06	137	122	6	81cdb216e6c81acf9c2072f9d39e1a42612e1258
ToppCell	LPS-antiTNF-Endothelial-Mes-Like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NEK10 EVI2B ACOX2 PPARGC1A ADAMTSL2 TBX6	4.93e-06	158	122	6	50df52d64d07178975563abd98ce4fddb9f2f7ef
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CA10 PPARGC1A RANBP3L RALGPS1 VAV3	5.29e-06	160	122	6	03b88dc7ad41c6ae443cab7e77ec666340bf432e
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE6A ODC1 AQP1 UBE2B RALGPS1 RNF10	5.69e-06	162	122	6	08ee7ae56e4927874515c47adc86dd845bf29a26
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L5 MECOM PTPN13 SHANK2 TMEM108 AKAP7	6.54e-06	166	122	6	c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STAB2 PTPN13 SHANK2 MKI67 TMEM108 CEP152	7.00e-06	168	122	6	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	367C-Fibroblasts-Fibroblast-G-\|367C / Donor, Lineage, Cell class and subclass (all cells)	APOB NEO1 RANBP3L ANTXR1 ELAVL2 TBX2	7.00e-06	168	122	6	b8c65542a0701ae31f49d332d87a64578e24b4e3
ToppCell	Control\|World / group, cell type (main and fine annotations)	EPB41L5 MECOM LDLR SHANK2 NAV2 AGBL1	7.00e-06	168	122	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	367C-Fibroblasts-Fibroblast-G\|367C / Donor, Lineage, Cell class and subclass (all cells)	APOB NEO1 RANBP3L ANTXR1 ELAVL2 TBX2	7.00e-06	168	122	6	8c95093b1ea45826f62893edd3c410fe53b563a4
ToppCell	TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	AOX1 ZNF804A ACOX2 PPARGC1A TMEM108 ARHGAP20	7.75e-06	171	122	6	cafcb7714110cb361808dbe4b9a4963bb71f5129
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SMG1 MBNL1 APOB LDLR PTPRC ARIH1	7.75e-06	171	122	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	facs-Aorta-Heart-3m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EVI2B ITGB7 PTPRC MKI67 GPR171 PLCG2	8.28e-06	173	122	6	513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDV3 EP400 LDLR RNF10 TRIM8 VAV3	9.74e-06	178	122	6	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC CST6 NAV2 TMEM108 PLCG2 AGBL1	9.74e-06	178	122	6	09a215a0d6e98e4bb920cabda12af08ff4de3c98
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMG1 MUC16 LDLR FER1L6 PLCG2 SORL1	1.01e-05	179	122	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L5 MECOM SLC1A1 SHANK2 NAV2 AKAP7	1.01e-05	179	122	6	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	facs-Aorta-Heart-3m-Myeloid-macrophage\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EVI2B ITGB7 PTPRC MKI67 GPR171 PLCG2	1.11e-05	182	122	6	df26388c0c46d1c4775103c8e802937b4d4e7470
ToppCell	facs-Aorta-Heart-3m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EVI2B ITGB7 PTPRC MKI67 GPR171 PLCG2	1.14e-05	183	122	6	062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 SLC1A1 PPARGC1A NAV2 VAV3 ATP1B2	1.14e-05	183	122	6	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 MBNL1 ZEB2 SAMD9L PTPRC SCAF11	1.18e-05	184	122	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	EPB41L5 MECOM PTPN13 SHANK2 TMEM108 AGBL1	1.21e-05	185	122	6	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L5 MECOM PTPN13 SHANK2 TMEM108 AGBL1	1.21e-05	185	122	6	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MON2 LDLR ZEB2 PTPRC NFAT5 ZNF292	1.21e-05	185	122	6	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 ZEB2 SAMD9L PTPRC SCAF11 VAV3	1.21e-05	185	122	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM LDLR PPARGC1A PTPN13 TBX2	1.25e-05	186	122	6	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM LDLR PPARGC1A PTPN13 TBX2	1.25e-05	186	122	6	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MECOM LDLR PTPN13 NAV2 AGBL1 AP3D1	1.25e-05	186	122	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	EPB41L5 MECOM LDLR PTPN13 SHANK2 NAV2	1.25e-05	186	122	6	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDV3 LDLR CLU RASSF1 ANTXR1 MAP2K3	1.29e-05	187	122	6	9c1013720c248ef201d010806b6e7ad24205e8ee
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	FEZ1 NAV2 TMEM108 ARHGAP20 ADAMTSL2 TBX2	1.29e-05	187	122	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CA10 PPARGC1A RANBP3L RALGPS1 NAV2	1.29e-05	187	122	6	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LDLR ZEB2 PTPN13 TMEM108 ARHGAP20 TBX2	1.29e-05	187	122	6	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CA10 PPARGC1A RANBP3L RALGPS1 NAV2	1.33e-05	188	122	6	2ee64bc73a2251fd9f374be759b442cf4ed0d19e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM CA10 PPARGC1A RANBP3L VAV3	1.33e-05	188	122	6	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 PTBP3 MECOM PTPN13 NFAT5 TBX2	1.37e-05	189	122	6	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM CA10 PPARGC1A NAV2 TMEM108	1.37e-05	189	122	6	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM CA10 PPARGC1A NAV2 TMEM108	1.37e-05	189	122	6	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM PPARGC1A PTPN13 RANBP3L VAV3 NFAT5	1.37e-05	189	122	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	EPB41L5 MECOM PTPN13 SHANK2 NAV2 TMEM108	1.37e-05	189	122	6	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MECOM CA10 PPARGC1A RANBP3L RALGPS1	1.41e-05	190	122	6	b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	ZEB2 FEZ1 VAV3 PLCG2 NFAT5 SORL1	1.41e-05	190	122	6	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 PTBP3 MECOM PPARGC1A PTPN13 TBX2	1.41e-05	190	122	6	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 MECOM PTPN13 PLCG2 NFAT5 TBX2	1.41e-05	190	122	6	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L5 SLC1A1 PPARGC1A SHANK2 NAV2 NRG3	1.41e-05	190	122	6	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CA10 PPARGC1A RANBP3L RALGPS1 NAV2	1.41e-05	190	122	6	3dcadabbefe0128a5f30ab51234f049ab4d870c6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTBP3 MBNL1 PTPRC MKI67 GPR171 RXFP1	1.45e-05	191	122	6	912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	MECOM PPARGC1A PTPN13 SHANK2 NAV2 TMEM108	1.45e-05	191	122	6	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTBP3 MBNL1 PTPRC MKI67 GPR171 RXFP1	1.45e-05	191	122	6	77a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AOX1 RANBP3L NAV2 ANTXR1 TMEM108 TBX2	1.45e-05	191	122	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MON2 LDLR ZEB2 PTPRC NFAT5 ZNF292	1.45e-05	191	122	6	9454f642c3621370fa23640b631301346b300950
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPB41L5 MECOM SLC1A1 SHANK2 NAV2 AGBL1	1.45e-05	191	122	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	MECOM AQP1 SLC1A1 CLU TMEM108 NRG3	1.50e-05	192	122	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF804A TENM2 SHANK2 ELAVL2 NRG3 CDH8	1.50e-05	192	122	6	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	control-Lymphoid-Treg\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	EVI2B CA10 ITGB7 ZEB2 PTPRC GPR171	1.50e-05	192	122	6	9067e90b7c2d734100d6e5026d753113bf9428a3
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	EPB41L5 MECOM PTPN13 SHANK2 NAV2 TMEM108	1.50e-05	192	122	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	TRPM6 OLFM4 MECOM PPARGC1A PTPN13 TBX2	1.50e-05	192	122	6	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AOX1 RANBP3L NAV2 ANTXR1 TMEM108 TBX2	1.50e-05	192	122	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 MECOM PTPN13 CLU TBX2 SORL1	1.50e-05	192	122	6	d5ec4cdb15620a5abfc83577353501186c2bc86a
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	RBMS2 MECOM SLC1A1 TMEM108 VAV3 NRG3	1.54e-05	193	122	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTBP3 MECOM PTPN13 CLU TBX2 SORL1	1.54e-05	193	122	6	5da60321bcf761913eb30779b6d8b1e933c5e51e
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	RBMS2 MECOM SLC1A1 TMEM108 VAV3 NRG3	1.54e-05	193	122	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 MBNL1 AQP1 VPS13A PLCG2 ZNF292	1.54e-05	193	122	6	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AOX1 TENM2 NAV2 TMEM108 ADAMTSL2 TBX2	1.54e-05	193	122	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
Drug	Succimer	SMG1 MBTD1 ANPEP AOX1 ZBTB8A MECOM ODC1 RFX7 ZNF804A ITGB7 ZEB2 ZNF518A PTPN11 SAMD9L PTPRC BRCA2 FEZ1 CLU RASSF1 MKI67 NAV2 VAV3 NFAT5 ZNF292 SORL1	9.91e-09	1264	121	25	ctd:D004113
Drug	Magnetite Nanoparticles	SMG1 MBTD1 ANPEP AOX1 ZBTB8A MECOM ODC1 RFX7 ZNF804A ITGB7 ZEB2 ZNF518A PTPN11 SAMD9L PTPRC BRCA2 FEZ1 CLU RASSF1 MKI67 NAV2 VAV3 NFAT5 ZNF292 SORL1	2.01e-08	1310	121	25	ctd:D058185
Drug	mesna	ANPEP MBNL1 OLFM4 AQP1 SHANK2	6.83e-06	50	121	5	CID000000598
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MBTD1 SYCP2 EHBP1L1 BRCA2 RALGPS1 RASSF1 CEP152 MAP2K3	8.17e-06	190	121	8	3253_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	PTBP3 CDV3 EPB41L5 BRCA2 ARIH2 CLTB AKAP7 TBX2	9.88e-06	195	121	8	7309_UP
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	PTBP3 MBNL1 ZNF804A BRCA2 FEZ1 ELAVL1 CDH8 AKAP7	1.06e-05	197	121	8	6494_DN
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	PLXNA3 PTBP3 ALPK1 SYCP2 EHBP1L1 RASSF1 CLTB NFAT5	1.10e-05	198	121	8	1533_DN
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; HL60; HT_HG-U133A	PTBP3 TCTN3 MBTD1 EP400 ALPK1 ZNF804A LDLR MAP2K3	1.10e-05	198	121	8	1838_DN
Disease	magnesium measurement	TRPM6 MECOM ALPK1 SKOR2 ELAVL2	7.81e-06	66	121	5	EFO_0004845
Disease	late-onset Alzheimers disease	NEK10 CEP295NL AOX1 MECOM SHANK2 CLU PLCG2 SORL1	2.86e-05	292	121	8	EFO_1001870
Disease	ovarian cancer (is_implicated_in)	MUC16 APOB BRCA2 RASSF1	8.38e-05	56	121	4	DOID:2394 (is_implicated_in)
Disease	Muckle-Wells Syndrome	ZEB2 PLCG2	1.65e-04	5	121	2	C0268390
Disease	alcohol consumption measurement	ENTHD1 ALPK1 ZNF804A TENM2 BRDT RALGPS1 ARIH2 ELAVL2 SCAF11 PEAK1 NFAT5 AGBL1 CCDC33 SORL1 TBX6	1.75e-04	1242	121	15	EFO_0007878
Disease	Prostate cancer, familial	MBNL1 MECOM RFX7 BRCA2	1.89e-04	69	121	4	C2931456
Disease	Seizures	PIGP SLC1A1 CLU TRIM8 AP3D1 ZNF292	2.88e-04	218	121	6	C0036572
Disease	LDL cholesterol change measurement	APOB LDLR	3.46e-04	7	121	2	EFO_0007804
Disease	atherosclerosis (implicated_via_orthology)	LDLR CLU	3.46e-04	7	121	2	DOID:1936 (implicated_via_orthology)
Disease	breast cancer (is_implicated_in)	PTPN13 BRCA2 CLU RASSF1 MKI67	3.93e-04	150	121	5	DOID:1612 (is_implicated_in)
Disease	thalamus volume	RFX7 PPARGC1A NAV2 NFAT5	4.22e-04	85	121	4	EFO_0006935
Disease	non-alcoholic fatty liver disease (implicated_via_orthology)	PPARGC1A UBE2A UBE2B	4.35e-04	36	121	3	DOID:0080208 (implicated_via_orthology)
Disease	chronic kidney disease, diabetic nephropathy	TENM2 PTPN13 NRG3	4.35e-04	36	121	3	EFO_0000401, EFO_0003884
Disease	Growth Disorders	BUB1B SECISBP2 ADAMTSL2	4.35e-04	36	121	3	C0018273
Disease	cerebellar ataxia (implicated_via_orthology)	GEMIN5 VPS13A	4.59e-04	8	121	2	DOID:0050753 (implicated_via_orthology)
Disease	Familial hypercholesterolemia	APOB LDLR	4.59e-04	8	121	2	cv:C0020445
Disease	Mental deterioration	CLU SORL1	5.89e-04	9	121	2	C0234985
Disease	Mild cognitive disorder	CLU SORL1	5.89e-04	9	121	2	C1270972
Disease	myocardial infarction	APOB CA10 LDLR ZEB2 EHBP1L1 PLCG2 AP3D1	6.18e-04	350	121	7	EFO_0000612
Disease	mean corpuscular hemoglobin concentration	EP400 MECOM ENTHD1 ZEB2 NEO1 EHBP1L1 PTPRC BRDT VPS13A ANTXR1 MAP2K3 AKAP7 TBX6	6.20e-04	1105	121	13	EFO_0004528
Disease	Colorectal Carcinoma	APOB ODC1 ZNF804A ZEB2 CABYR BUB1B VPS13A MKI67 ZNF292 SORL1	6.45e-04	702	121	10	C0009402
Disease	proteinuria (biomarker_via_orthology)	ZEB2 CLU	7.35e-04	10	121	2	DOID:576 (biomarker_via_orthology)
Disease	response to carboplatin, response to antineoplastic agent	AKNAD1 PLCG2	7.35e-04	10	121	2	GO_0097327, GO_0097328
Disease	familial hypercholesterolemia (is_implicated_in)	APOB LDLR	7.35e-04	10	121	2	DOID:13810 (is_implicated_in)
Disease	Atrophic	SLC1A1 CLU	7.35e-04	10	121	2	C0333641
Disease	Alzheimer disease	TENM2 CLU CST6 CSTB ANTXR1 PLCG2 ARHGAP20 SORL1	8.96e-04	485	121	8	MONDO_0004975
Disease	systemic lupus erythematosus (is_marker_for)	LDLR CLU MKI67	9.56e-04	47	121	3	DOID:9074 (is_marker_for)
Disease	Prostatic Neoplasms	STAB2 PIGP AOX1 PTPRC BRCA2 CLU CST6 VAV3 ZNF292	1.01e-03	616	121	9	C0033578
Disease	Malignant neoplasm of prostate	STAB2 PIGP AOX1 PTPRC BRCA2 CLU CST6 VAV3 ZNF292	1.01e-03	616	121	9	C0376358
Disease	red blood cell density measurement	EP400 MBNL1 EPB41L5 MECOM RFX7 ZEB2 PPARGC1A PTPRC ANTXR1 AP3D1 TBX6	1.01e-03	880	121	11	EFO_0007978
Disease	urate measurement, bone density	TRPM6 CA10 TENM2 PPARGC1A ARIH2 ELAVL2 VWA3B TMEM108 PEAK1	1.05e-03	619	121	9	EFO_0003923, EFO_0004531
Disease	forced expiratory volume, traffic air pollution measurement	CA10 NAV2	1.07e-03	12	121	2	EFO_0004314, EFO_0007908
Disease	reticulocyte count	GEMIN5 PTPN11 PTPRC RANBP3L RASSF1 DNAH17 VPS13A RNF10 ANTXR1 PLCG2 MAP2K3 TBX6	1.24e-03	1045	121	12	EFO_0007986
Disease	Hyperlipoproteinemia Type IIb	APOB LDLR	1.26e-03	13	121	2	C1704417
Disease	low density lipoprotein cholesterol measurement, lipid measurement	APOB LDLR PTPN11 BRCA2	1.27e-03	114	121	4	EFO_0004529, EFO_0004611
Disease	susceptibility to bacterial meningitis measurement	CA10 NFAT5 AKAP7	1.28e-03	52	121	3	EFO_0008411
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	NEK10 MECOM BRCA2	1.28e-03	52	121	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	OLFM4 ENTHD1 ZNF804A TENM2 TRIM8	1.43e-03	200	121	5	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	Impaired cognition	CLU SORL1	1.47e-03	14	121	2	C0338656
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB LDLR	1.47e-03	14	121	2	EFO_0004611, EFO_0008589
Disease	memory performance	MECOM LDLR STAB1 NEO1 VAV3 AGBL1 SORL1	1.52e-03	409	121	7	EFO_0004874
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	APOB LDLR PTPN11 BRCA2	1.53e-03	120	121	4	EFO_0004611, EFO_0004639
Disease	response to statin, LDL cholesterol change measurement	APOB LDLR	1.69e-03	15	121	2	EFO_0007804, GO_0036273
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	APOB LDLR PTPN11 BRCA2	1.83e-03	126	121	4	EFO_0004611, EFO_0010351
Disease	adverse effect, response to xenobiotic stimulus	STAB2 NAV2 VWA3B	1.85e-03	59	121	3	EFO_0009658, GO_0009410
Disease	depressive symptom measurement	MBNL1 OLFM4 ZNF804A TENM2 STAB1 PPARGC1A ELAVL2	1.92e-03	426	121	7	EFO_0007006
Disease	Hyperlipoproteinemia Type IIa	APOB LDLR	1.93e-03	16	121	2	C0745103
Disease	syndromic intellectual disability (implicated_via_orthology)	UBE2A UBE2B	1.93e-03	16	121	2	DOID:0050888 (implicated_via_orthology)
Disease	Schizoaffective disorder-bipolar type	STAB2 ZNF804A	1.93e-03	16	121	2	EFO_0009965
Disease	Early infantile epileptic encephalopathy with suppression bursts	PIGP TRIM8	1.93e-03	16	121	2	C0393706
Disease	PROSTATE CANCER, HEREDITARY, 1	MBNL1 MECOM RFX7	1.94e-03	60	121	3	C4722327
Disease	Lipidemias	APOB LDLR	2.18e-03	17	121	2	C1706412
Disease	respiratory symptom change measurement, response to placebo	PPARGC1A NAV2	2.18e-03	17	121	2	EFO_0008344, EFO_0010068
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 ZNF292	2.18e-03	17	121	2	DOID:0060307 (is_implicated_in)
Disease	Hyperlipidemia	APOB LDLR	2.18e-03	17	121	2	C0020473
Disease	ovarian neoplasm	MUC16 MECOM BRCA2 MKI67	2.29e-03	134	121	4	C0919267
Disease	Feeding difficulties	PIGP ZNF292	2.44e-03	18	121	2	C0232466
Disease	Hypercholesterolemia, Familial	APOB LDLR	2.44e-03	18	121	2	C0020445
Disease	Malignant neoplasm of ovary	MUC16 MECOM BRCA2 MKI67	2.48e-03	137	121	4	C1140680
Disease	Intellectual Disability	PIGP ODC1 SHANK2 TRIM8 CSTB MED23 ZNF292	2.51e-03	447	121	7	C3714756
Disease	carotid artery intima media thickness	APOB BOD1L2 ZNF804A TENM2 NAV2 SPATA22 CDH8	2.61e-03	450	121	7	EFO_0007117
Disease	MYELODYSPLASTIC SYNDROME	MECOM PTPN11 BRCA2	2.66e-03	67	121	3	C3463824
Disease	sodium-coupled monocarboxylate transporter 1 measurement	APOB LDLR	2.72e-03	19	121	2	EFO_0802076
Disease	Malignant neoplasm of urinary bladder	ANPEP BRCA2 RALGPS1 RASSF1	2.76e-03	141	121	4	C0005684
Disease	hematocrit	LYPLAL1 RBMS2 MBNL1 EPB41L5 MECOM APOB STAB1 PPARGC1A NFAT5 AP3D1 TBX6	3.00e-03	1011	121	11	EFO_0004348
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOB LDLR	3.33e-03	21	121	2	EFO_0022246
Disease	cortical surface area measurement	MON2 TRPM6 MECOM TENM2 NEO1 RALGPS1 TRIM8 NAV2 ELAVL2 MED23 AGBL1 CCDC33 TBX6	3.54e-03	1345	121	13	EFO_0010736
Disease	diet measurement, fasting blood insulin measurement	NRG3 AGBL1	3.65e-03	22	121	2	EFO_0004466, EFO_0008111
Disease	clinical and behavioural ideal cardiovascular health	LDLR NFAT5	3.99e-03	23	121	2	EFO_0007654
Disease	diet measurement, HOMA-IR	NRG3 AGBL1	3.99e-03	23	121	2	EFO_0004501, EFO_0008111
Disease	gut microbiome measurement, bone density	TCTN3 IMPG1 PPARGC1A	4.09e-03	78	121	3	EFO_0003923, EFO_0007874

Protein segments in the cluster

Peptide	Gene	Start	Entry
DPYDCNKNNQALKIV	BUB1B	896	O60566
QNQKYQGTVKPTFRN	CEP295NL	431	Q96MC4
QQKVAYAAQPALKTQ	EP400	3006	Q96L91
KVLDYQTQQQKLFPQ	ACOX2	336	Q99424
NKVTYKPYQSSAQNN	CEP152	191	O94986
AQKLANQASNYAESP	nan	491	Q9N2J8
RVKNNQPAKYPLNNA	ANTXR1	486	Q9H6X2
QAQQPQAALLKQYQG	CCDC33	731	Q8N5R6
KNVLPDSQQQYNVVK	BRDT	251	Q58F21
AVQQYLEETQNKNKP	AKAP7	311	Q9P0M2
KPAYQNLSQKADNFV	BOD1L2	66	Q8IYS8
QFNRPFNEAASKNKQ	C4orf47	31	A7E2U8
KYPVGNNQTAVQDNV	AQP1	36	P29972
LYQAFNGLKNKNSQL	CHIA	76	Q9BZP6
ENKPLTLSNYQTNKA	CSTB	76	P04080
LKTNPSNINQFAAAY	CABYR	26	O75952
NQSQQAQAREALKKY	ARIH2	351	O95376
VVYSQEKNKNANSSP	ANPEP	31	P15144
YQDSPNQKKRTNGLQ	DCP2	326	Q8IU60
SKNQALKLQLDNQYA	CDV3	231	Q9UKY7
KNDYEKFKNNPQINL	ALPK1	251	Q96QP1
KKNPGVNLYQNVQSN	AGBL1	431	Q96MI9
ARKQEQANNPFYIKS	AP3D1	671	O14617
QTPYKQEINAKNLIQ	AOX1	961	Q06278
YNRNNKKPYVSLAQQ	RBMS2	16	Q15434
QKIKEYNAQINSNLF	RASSF1	141	Q9NS23
QLNNPDKGNVYKFQT	RALGPS1	511	Q5JS13
LQNLASINNKKEYSN	MECOM	626	Q03112
YLKKNNQSIIFENNQ	ARIH1	481	Q9Y4X5
QIQEQLKVPQNGKSY	NRG3	391	P56975
VINKAYQKPAQSSIQ	ENTHD1	381	Q8IYW4
QDKAQPGTTNYQRNK	MUC16	14336	Q8WXI7
QYQATLQNQAKTKAA	MBTD1	121	Q05BQ5
QAYKTSVKKFQNQQN	IMPG1	756	Q17R60
NKFLEPYNDSIQAQK	ATP1B2	111	P14415
AKNLPQPQSGQKNYE	PLXNA3	706	P51805
ENIESINQNKAPLKY	NEK10	501	Q6ZWH5
KPSEDIYKNWQQQQQ	FAM157A	61	C9JC47
KSPNLSEIKFNSYNN	PEAK1	586	Q9H792
TNNLYQMKSQNPLAK	PDE6A	606	P16499
LDTTSNKQTPQKNNY	EVI2B	186	P34910
NKQTPQKNNYNSIAA	EVI2B	191	P34910
DNENYPNVKKALINI	GPR171	211	O14626
NNVPQESRFNLKKNV	MED23	746	Q9ULK4
YASLDPLNIKQNNKQ	EHBP1L1	1086	Q8N3D4
NGNYKVDSPKNFNIA	ADAMTSL2	266	Q86TH1
NYNAKTENLAPVKNQ	FEZ1	76	Q99689
TEQNNSSQPSKQKYV	LRRC42	401	Q9Y546
VKFAANPNQNKNVAL	ELAVL1	181	Q15717
NPNQNKNVALLSQLY	ELAVL1	186	Q15717
KTPVQYSQQQNSPQK	MKI67	346	P46013
YSQQQNSPQKHKNKD	MKI67	351	P46013
NTYNVVKAPQGKNQK	PLCG2	856	P16885
QENKNKNRYKNILPF	PTPN11	271	Q06124
ANAKYNQIQLFAPAE	MON2	1386	Q7Z3U7
PSENEKQQQIQPKAY	NFAT5	656	O94916
KPADAAQYLQQQAKL	FOXB1	121	Q99853
QQLNWKQDSNPLYKS	ITGB7	766	P26010
SNQYNNEPSNIFEKI	PPARGC1A	66	Q9UBK2
SDKFYKQTVNLQLQP	APOB	1776	P04114
QTPAQAETNYLNKAK	EPB41L5	211	Q9HCM4
ISNVKDANAYPQTVN	BRCA2	1791	P51587
KYLNFQQQKEIPDSA	DNAH17	686	Q9UFH2
NDLNKINPVYQFSLK	DNAH17	3666	Q9UFH2
NAKIAYKQNKANTAQ	GJC1	306	P36383
QSVFKEPNNENKNAL	GOLGA8J	371	A6NMD2
KSYQGQSPQKQQTEK	AKNAD1	226	Q5T1N1
KFANNPSQKTNQAIL	ELAVL2	201	Q12926
KIKAAQYQVNQAAAA	MBNL1	246	Q9NR56
LNKASAVYQALQKSN	LYPLAL1	151	Q5VWZ2
NKDKTDLPQSVVYQN	CEP192	461	Q8TEP8
PQVQKAAQAAVASYN	CST6	46	Q15828
PSSNQNVNSKVNKYY	EEF2K	46	O00418
NPYDKNAIKVNNVNG	HLTF	91	Q14527
NNPNFTIKKNEDNSL	CDH8	541	P55286
QGKDCPNNRAQKLQY	CA10	306	Q9NS85
SQQVNYIASQPDGKQ	SCAF11	1286	Q99590
NQQQKKYQEEAIPAL	PIGP	121	P57054
ANPCKQVSQIKYAAN	ODC1	111	P11926
PENLVQACFQQYKTK	SLC1A1	151	P43005
SLYQPLQNSSKEKND	PTPN13	941	Q12923
INPELNQKGYNVKSD	MAP2K3	236	P46734
IQSYKNNPNFSIQAD	FER1L6	1031	Q2WGJ9
SQKDEDYLKQNQPLQ	ARHGAP20	736	Q9P2F6
PQGYQLKNNTCVKQE	SORL1	1061	Q92673
ALQTLKPNFQQNQYK	SPATA22	196	Q8NHS9
VNEYAFLLQQNSKKP	SAMD9L	1361	Q8IVG5
AALQAQKAQDSYQTP	SMG1	2226	Q96Q15
KTNIPANTKYKNANA	NEO1	896	Q92859
SLSRYKQQQQQPQKQ	NAV2	186	Q8IVL1
KFQSKQQPQDNFKNN	SECISBP2	426	Q96T21
SKNKPVLNAFNQYEA	TENM2	1571	Q9NT68
KNNAYLAQSPQLYKQ	DARS1	241	P14868
EKVQSINYNPFDQKL	OLFM4	476	Q6UX06
NKELKNYNSQTPFQV	SHANK2	356	Q9UPX8
KSIYQVENLKQPFQS	BTG4	166	Q9NY30
KINNRIADKAFYQQP	CLTB	151	P09497
NQGSKYVNKEIQNAV	CLU	36	P10909
QQPTDSLNNDNKYSL	USP22	451	Q9UPT9
EKAFNQFPNLTRQNK	ZNF846	176	Q147U1
KNVPDLKSTYNNVLQ	VPS13A	971	Q96RL7
NKYNYHPASQKNTQQ	ZBTB8A	181	Q96BR9
AAQKLIYTFNQVKPQ	TRPM6	1836	Q9BX84
YQNDKITQLKIDNNP	TBX2	266	Q13207
QKLTQPQLENDSYAK	RANBP3L	226	Q86VV4
QQNHPKYSGQKNTEN	SYCP2	696	Q9BX26
KRELSYPKNESFNNQ	RNF10	66	Q8N5U6
QKLQNIKYPSATNNT	GEMIN5	1181	Q8TEQ6
KANNLNTPNNGKFVY	ZNF292	1141	O60281
PANSQAAQLYQENKR	UBE2A	121	P49459
LSYNPIQKIQANQFD	RXFP1	326	Q9HBX9
KDQPQQTFNIYKANN	STAB1	466	Q9NY15
APNNNAIENYIREKK	STAB2	1176	Q8WWQ8
AYQNPQITQLKIAAN	TBX6	251	O95947
QTAFPNALQKQANSK	RFX7	1136	Q2KHR2
KLVQNSTYQNIQPKK	ZNF518A	1121	Q6AHZ1
KNNQFQALLQYADPV	PTBP3	216	O95758
QPSYKDSQKTKENNQ	SKOR2	866	Q2VWA4
KNYANKAPGEQQKLQ	VWA3B	1006	Q502W6
KQANPRRKNVVNYDN	ZEB2	16	O60315
NSNLNYFQKLQKVNA	TCTN3	166	Q6NUS6
NQAYNQKPGLEKNLK	TRIM8	56	Q9BZR9
EENKSKNRNSNVIPY	PTPRC	966	P08575
ASTYPAQNGQVKKNN	PTPRC	1226	P08575
PANSQAAQLYQENKR	UBE2B	121	P63146
KKTANPENNLSYWNN	TMEM108	496	Q6UXF1
DPESANNYTAKNNQV	ZNF804A	186	Q7Z570
DLQQYKIANNPTTDK	VAV3	446	Q9UKW4
KNINSINFDNPVYQK	LDLR	816	P01130